140 related articles for article (PubMed ID: 33946406)
1. Arsenicals, the Integrated Stress Response, and Epstein-Barr Virus Lytic Gene Expression.
Lee J; Stone J; Desai P; Kosowicz JG; Liu JO; Ambinder RF
Viruses; 2021 Apr; 13(5):. PubMed ID: 33946406
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.
Lee J; Kosowicz JG; Hayward SD; Desai P; Stone J; Lee JM; Liu JO; Ambinder RF
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341058
[TBL] [Abstract][Full Text] [Related]
3. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.
Verma D; Church TM; Swaminathan S
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13044-13055. PubMed ID: 32434920
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
Huang L; Yang M; Yuan Y; Li X; Kuang E
Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
[TBL] [Abstract][Full Text] [Related]
7. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr virus (
Yakushina SA; Kisteneva LB
Vopr Virusol; 2020 Sep; 65(4):191-202. PubMed ID: 33533222
[TBL] [Abstract][Full Text] [Related]
9. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
10. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I
Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
12. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
13. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
14. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
[TBL] [Abstract][Full Text] [Related]
15. Effect of Pinus massoniana Lamb. bark extract on lytic cycle of Epstein-Barr virus.
Xu S; Zhang S; Wang X; Gao Y; Qin X; Wu K
Indian J Exp Biol; 2012 Oct; 50(10):708-13. PubMed ID: 23214264
[TBL] [Abstract][Full Text] [Related]
16. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
17. Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.
Zhang K; Lv DW; Li R
Virology; 2020 Jan; 540():75-87. PubMed ID: 31743858
[TBL] [Abstract][Full Text] [Related]
18. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
[TBL] [Abstract][Full Text] [Related]
19. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
[TBL] [Abstract][Full Text] [Related]
20. Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.
Choi SJ; Ryu E; Lee S; Huh S; Shin YS; Kang BW; Kim JG; Cho H; Kang H
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875759
[No Abstract] [Full Text] [Related]
[Next] [New Search]